Soft launch of first indigenous antibiotic to combat AMR, Nafithromycin, announced by Dr Jitendra… Press Information Bureau Nov 21, 2024 The development of Nafithromycin represents 14 years of research and an investment of ₹500 crores, with clinical trials spanning…
CDSCO committee recommends Wockhardt’s novel antibiotic Miqnaf for CABP treatment EP News Bureau Oct 11, 2024 The recommendation clears the path for final approval from the DCGI following extensive clinical studies
Wockhardt and Jemincare partner for novel respiratory antibiotic Nafithromycin EP News Bureau Aug 26, 2021 Wockhardt to receive upfront and milestone payments, in addition to royalties
